Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Journal of Clinical Psychopharmacology
|
October 9, 2015
Intensive Design to Reinvigorate Psychiatric Drug Development
Donald F Klein, Ira D Glick
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 25, 2008
Conflict of interest, journal review, and publication policy
Donald F Klein, Ira D Glick
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 12, 2014
Industry withdrawal from psychiatric medication development
Donald F Klein, Ira D Glick
Journal of Clinical Psychopharmacology
|
August 27, 2011
Central nervous system drug development, basic, and clinical research: thinking outside the box
Donald F Klein, Ira D Glick, Richard I Shader
JAMA Psychiatry
|
November 13, 2015
Whither Research Domain Criteria (RDoC)?: The Good, the Bad, and the Ugly
Daniel R Weinberger, Ira D Glick, Donald F Klein
Journal of Clinical Psychopharmacology
|
August 13, 2002
A typological model for estimation of drug and placebo effects in depression
Donald C Ross, Frederick M Quitkin, Donald F Klein
The American Journal of Psychiatry
|
October 3, 2009
Clinical trials design lessons from the CATIE study
Helena Chmura Kraemer, Ira D Glick, Donald F Klein
Psychiatry Research
|
December 13, 2006
Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder
Smit S Sinha, Raymond R Goetz, Donald F Klein
The American Psychologist
|
March 20, 2002
Comparison of medical and psychological tests
Howard N Garb, Donald F Klein, William M Grove
European Archives of Psychiatry and Clinical Neuroscience
|
November 26, 2009
Improved statistical analysis of moclobemide dose effects on panic disorder treatment
Donald C Ross, Donald F Klein, E H Uhlenhuth
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Journal of Clinical Psychopharmacology
|
October 9, 2015
Intensive Design to Reinvigorate Psychiatric Drug Development
Donald F Klein, Ira D Glick
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 25, 2008
Conflict of interest, journal review, and publication policy
Donald F Klein, Ira D Glick
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 12, 2014
Industry withdrawal from psychiatric medication development
Donald F Klein, Ira D Glick
Journal of Clinical Psychopharmacology
|
August 27, 2011
Central nervous system drug development, basic, and clinical research: thinking outside the box
Donald F Klein, Ira D Glick, Richard I Shader
JAMA Psychiatry
|
November 13, 2015
Whither Research Domain Criteria (RDoC)?: The Good, the Bad, and the Ugly
Daniel R Weinberger, Ira D Glick, Donald F Klein
Journal of Clinical Psychopharmacology
|
August 13, 2002
A typological model for estimation of drug and placebo effects in depression
Donald C Ross, Frederick M Quitkin, Donald F Klein
The American Journal of Psychiatry
|
October 3, 2009
Clinical trials design lessons from the CATIE study
Helena Chmura Kraemer, Ira D Glick, Donald F Klein
Psychiatry Research
|
December 13, 2006
Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder
Smit S Sinha, Raymond R Goetz, Donald F Klein
The American Psychologist
|
March 20, 2002
Comparison of medical and psychological tests
Howard N Garb, Donald F Klein, William M Grove
European Archives of Psychiatry and Clinical Neuroscience
|
November 26, 2009
Improved statistical analysis of moclobemide dose effects on panic disorder treatment
Donald C Ross, Donald F Klein, E H Uhlenhuth
Page
of 7